COMP <GO>
JBS vs COST // ALTMAN Z-SCORE & DEBT/EQUITY
JBS N.V. Class A (NYSE) VS. Costco Wholesale Corporation (NASDAQ) • 15-METRIC TALLY: JBS 9
— COST 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: COST
LAST: $12.49 (+2.71%) • MKT CAP: $13.02B
balance-sheet
3.74
LAST: $1,012.28 (+1.63%) • MKT CAP: $448.57B
balance-sheet
9.38
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBS VS. COST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JBS | COST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 12.82% | +28.18 | JBS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 42.43% | -32.53 | COST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 31.4x | -10.36 | JBS | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.09% | +0.12 | JBS | /fcf-yield <GO> |
| Operating Margin | 13.90% | 3.85% | +10.05 | JBS | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 3.04% | +7.86 | JBS | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | 10.14% | +7.46 | JBS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.58% | -0.58 | COST | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.74 | 9.38 | -5.64 | COST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | JBS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 4.46% | +2.64 | COST | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 66.5 | -14.67 | COST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.73 | +0.34 | JBS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 39.7x | -12.12 | JBS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.02B | $448.57B | -$435.55B | COST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JBS REV | COST REV | JBS GROSS % | COST GROSS % | JBS FCF | COST FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $303.15B | — | 12.8% | — | $9.38B |
| FY 2025 | — | $275.24B | — | 12.8% | — | $7.84B |
| FY 2024 | — | $254.45B | — | 12.6% | — | $6.63B |
| FY 2023 | — | $242.29B | — | 12.3% | — | $6.75B |
| FY 2022 | — | $226.95B | — | 12.2% | — | $3.50B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBS // BETA 1.07
COST // BETA 0.73